Senseonics Investor Relations Material
Latest events
Q1 2025
Senseonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senseonics Holdings Inc
Access all reports
Senseonics Holdings Inc. is a medical technology company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. The company’s flagship product, the Eversense CGM System, includes a long-term implantable sensor, a wearable transmitter, and a mobile app, providing real-time glucose readings and trend data. Eversense is designed to reduce the frequency of sensor replacements compared to traditional CGM systems. The company is headquartered in Germantown, Maryland, and its shares are listed on the NYSE.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
SENS
Country
🇺🇸 United States